Skip to content
Exams
Emergency
Intensive Care
Anaesthesia
Surgery
Internal Medicine
General Practice
Other Specialties
Study Guides
Practice and Tools
Start free trial
Home  /  FRANZCP  /  Study notes  /  Sexual disorders and gender dysphoria

Sexual disorders and gender dysphoria

FRANZCP LO RANZCP_S2_A15.11LO RANZCP_S2_C5.3 3,078 words
Free preview. This study note covers 2 learning objectives (RANZCP_S2_A15.11, RANZCP_S2_C5.3) from the FRANZCP curriculum. Inside Primex you get AI-graded SAQ practice on this topic, voice viva with the AI examiner, MCQs across the full syllabus, and a curriculum tracker that ticks off every learning objective.

Overview

Paraphilic disorders occupy a unique intersection of clinical psychiatry, forensic practice, and public policy. The term paraphilia derives from the Greek roots para ("alongside") and philia ("love"), etymologically, "love alongside the norm", and refers to any intense and persistent sexual interest other than sexual interest in genital stimulation or preparatory fondling with phenotypically normal, physically mature, consenting human partners (DSM-5/DSM-5-TR definition).

Under DSM-5-TR, a paraphilia becomes a paraphilic disorder only when it is accompanied by clinically significant distress or functional impairment, or when its enactment has entailed, or risks entailing, harm to non-consenting others. Non-normative sexual interest is therefore not itself a mental disorder; this distinction carries major clinical and legal weight.

ICD-11 similarly replaced the ICD-10 section "Disorders of Sexual Preference" with "Paraphilic Disorders," reflecting a parallel shift away from pathologising unconventional sexuality per se toward defining disordered or harmful sexual behaviour.

Psychiatrists in forensic, correctional, or general adult settings encounter paraphilic disorders across a spectrum from voluntary outpatient presentations to civil commitment proceedings. Competency in assessment, diagnosis, evidence-based management, and the medicolegal framework is essential for RANZCP fellowship practice.


Epidemiology

Paraphilic disorders are predominantly identified in male clinical and forensic populations, though this likely reflects ascertainment bias rather than a true sex difference in prevalence.

Key epidemiological findings:

Clinical and forensic research populations overrepresent incarcerated and civilly committed individuals, limiting generalisability. Paraphilic interests emerge in adolescence and early adulthood, follow a generally chronic course, and rarely develop de novo in later life, late-onset presentations should prompt consideration of neurological or medical aetiology.


Aetiology and Pathophysiology

The aetiology of paraphilias remains incompletely understood; both biological and psychosocial factors are implicated.

Biological Factors

Psychosocial Factors

Comorbidity

Paraphilic disorders show high comorbidity with multiple psychiatric categories. The presence of one paraphilic disorder substantially increases the likelihood of additional paraphilic behaviours (paraphilic crossover).

Comorbid Category Examples
Mood disorders Major depressive disorder, bipolar disorder
Anxiety disorders Social anxiety disorder
Personality disorders Antisocial, narcissistic, psychopathic features most strongly associated
Substance use disorders Alcohol, stimulant use disorders
Neurodevelopmental disorders ADHD, intellectual disability
Other paraphilic disorders High crossover rates across subtypes

Classification and Diagnostic Criteria

DSM-5-TR Paraphilic Disorders

Disorder Core Focus of Deviant Arousal
Voyeuristic disorder Observing unsuspecting persons who are naked, disrobing, or engaged in sexual activity
Exhibitionistic disorder Exposing genitals to an unsuspecting person
Frotteuristic disorder Touching or rubbing against a non-consenting person
Sexual masochism disorder Being humiliated, beaten, bound, or made to suffer
Sexual sadism disorder Inflicting physical or psychological suffering on another person
Pedophilic disorder Sexual focus on prepubescent children (generally ≤13 years); diagnosable from age ≥16 with victim at least 5 years younger
Fetishistic disorder Non-living objects or specific non-genital body parts
Transvestic disorder Sexually arousing cross-dressing
Other specified / unspecified paraphilic disorder Clinically significant presentations not captured above (e.g. necrophilia, zoophilia, urophilia, coprophilia)

Diagnostic Framework

Criterion A (paraphilia): Intense and persistent sexual arousal to the specified stimulus, manifested by fantasies, urges, or behaviours, present for at least 6 months.

Criterion B (paraphilic disorder): The individual has acted on these urges with a non-consenting person, OR the urges or fantasies cause clinically significant distress or impairment in social, occupational, or other areas of functioning.

Course Specifiers (DSM-5-TR)

Specifiers apply to most paraphilic disorders, with three exceptions: pedophilic disorder, other specified paraphilic disorder, and unspecified paraphilic disorder.

Specifier Meaning
In a controlled environment Absence of paraphilic urges in a setting that restricts opportunities to act on them
In full remission No acting on urges with a non-consenting person AND no distress or impairment for ≥5 years while in an uncontrolled environment

ICD-11 Classification

ICD-11 classifies paraphilic disorders similarly, requiring that the arousal pattern causes distress, functional impairment, or involves non-consenting persons. The replacement of "Disorders of Sexual Preference" with "Paraphilic Disorders" mirrors DSM-5 in distinguishing pathological from merely unconventional sexuality. ICD-11 also introduced Compulsive Sexual Behaviour Disorder (CSBD) as a separate entity under impulse-control disorders, this is not a paraphilic disorder per se.

Paraphilia-Related Disorders and Hypersexual Disorder

A second group of sexual impulse disorders involves behaviours not considered socially "deviant" (e.g. excessive masturbation, protracted promiscuity) but producing impairment analogous to paraphilic disorders. These were designated paraphilia-related disorders by Kafka. Key points:


Assessment

Clinical Psychiatric Evaluation

A comprehensive evaluation includes:

Objective Assessments

Given the reluctance of individuals with paraphilic disorders to self-disclose, objective assessments are important adjuncts:

Instrument Description Setting
Penile plethysmography (phallometry) Measures penile circumference change in response to audiovisual stimuli Specialist forensic; identifies sexual interest profile independent of self-report; also used to monitor treatment response
Visual reaction time (VRT) Measures viewing time for images of persons of varying age and sex Non-invasive index of sexual interest
Sexual history polygraph Physiological responses during structured interview More common in mandated treatment programs than routine clinical settings; not diagnostic in isolation

Psychological testing has no established diagnostic role in paraphilic disorders.

Risk Assessment Tools

Tool Type Focus
Static-99R Actuarial Static risk factors for sexual reoffending
SVR-20 Structured professional judgement (SPJ) Sexual violence risk, static and dynamic
RSVP SPJ Comprehensive sexual violence risk
STABLE-2007 / ACUTE-2007 Dynamic actuarial Changeable risk factors; used alongside Static-99R

Differential Diagnosis

Diagnosis Distinguishing Features
Paraphilic interest (not disorder) Intense sexual interest without distress, impairment, or harm to others, not a mental disorder
OCD Intrusive sexual thoughts experienced as ego-dystonic; no arousal component; responds to SRI treatment
Major depressive disorder / bipolar disorder Hypersexual behaviour or unusual sexual interests secondary to mood episode; resolves with mood stabilisation
Psychotic disorder Sexual behaviours emerging in context of active psychosis; not a paraphilic disorder if temporally linked to psychotic episode
CSBD (ICD-11) Repetitive difficult-to-control sexual behaviour; not necessarily paraphilic; recognised in ICD-11 but absent from DSM-5-TR
Neurodegenerative / acquired neurological disorder New-onset disinhibited or paraphilic-appearing behaviour (frontotemporal dementia, TBI, Huntington disease, Parkinson disease on dopaminergic therapy), represents a neurological phenomenon, not a primary paraphilic disorder
Antisocial personality disorder Sexual offending without paraphilia; opportunistic rather than driven by deviant arousal

Key principle: Paraphilic interests typically emerge in adolescence and are present chronically. Emergence of unusual sexual interests later in life, especially in the context of psychiatric decompensation, psychosis, or neurological illness, argues strongly against a primary paraphilic disorder.


Management

Pharmacological Treatment

The stepwise model moves from less to more potent agents based on clinical severity and risk:

$$\text{SSRIs} \rightarrow \text{oral antiandrogens} \rightarrow \text{depot GnRH agonists}$$

SSRIs and Serotonergic Agents

First-line for mild-moderate paraphilic disorders, non-offending presentations, or lower-risk cases. SSRIs reduce libido modestly and attenuate obsessional sexual ideation. Both SSRIs and antiandrogens can ameliorate paraphilias and paraphilia-related disorders.

Drug Dose Range Notes
Sertraline 50-200 mg/day Standard first-line choice
Fluoxetine 20-80 mg/day Alternative first-line
Fluvoxamine 100-300 mg/day Preferred where OCD-spectrum features are prominent

Antiandrogen and Hormonal Agents

Reserved for higher-risk presentations, persistent or severe paraphilic disorders, or SSRI failure. These agents substantially suppress testosterone and sexual drive.

Drug Mechanism Route / Dose Monitoring
Medroxyprogesterone acetate (MPA) Progestogen; suppresses LH/FSH; reduces testosterone Oral 60-150 mg/day or IM depot LFTs, lipids, weight, bone density, glucose
Cyproterone acetate (CPA) Androgen receptor antagonist + progestogen; suppresses LH Oral 50-200 mg/day or IM depot LFTs, adrenal function, cardiovascular
Leuprorelin (GnRH agonist) Initial LH flare then sustained suppression → castrate testosterone levels SC/IM depot monthly or 3-monthly Testosterone, DEXA, metabolic parameters
Triptorelin (GnRH agonist) Same mechanism as leuprorelin IM depot 3-monthly As for leuprorelin

Long-acting GnRH agonists are highly effective but carry significant adverse effects: osteoporosis, metabolic syndrome, hot flushes, and cardiovascular risk. Calcium, vitamin D supplementation, and DEXA monitoring are recommended with sustained therapy.


Psychological Interventions

Cognitive-Behavioural Therapy (CBT)

The most evidence-supported psychological approach. Key components:

Research consistently demonstrates that structured CBT is more effective in reducing reoffending than didactic, non-directive, or psychodynamic approaches. Recidivism rates from structured CBT programs range from approximately 3% to 31% across studies. Therapist qualities, specifically a non-judgmental, empathic stance, independently predict treatment effectiveness regardless of modality.

Strength-Based Rehabilitation Models

Current evidence-based programs favour these approaches:

Model Core Principle
Good Lives Model (GLM) Identifies offenders' primary human goods; develops prosocial means to achieve them; addresses underlying needs driving offending
Risk-Need-Responsivity (RNR) Model Treatment intensity matched to risk level; targets criminogenic needs; delivery adapted to offender learning style

Behavioural Techniques

Technique Description
Aversion conditioning Pairing paraphilic stimuli with aversive stimuli (olfactory or electrical); classical conditioning to extinguish arousal
Covert sensitisation Imaginal pairing of paraphilic fantasy with aversive imagery
Masturbatory reconditioning Directing masturbatory fantasy toward non-paraphilic stimuli
Imaginal desensitisation Repeated non-reinforced imaginal exposure to reduce arousal responses

All behavioural techniques rely on classical (Pavlovian) conditioning principles. Evidence is largely from uncontrolled studies; success of aversion conditioning appears to depend on the availability of appropriate sexual outlets and absence of severe comorbidity.


Social and Community Interventions


Prognosis


Special Populations

Adolescents

Older Adults

Neurodevelopmental Disorders


Medicolegal and Ethical Considerations

Civil Commitment of Sexually Dangerous Persons

In Australia, all states and territories have legislation enabling post-sentence preventive detention or extended supervision orders for high-risk sex offenders:

Jurisdiction Legislation
Queensland Dangerous Prisoners (Sexual Offenders) Act 2003
Victoria Serious Sex Offenders (Detention and Supervision) Act 2009
Western Australia Dangerous Sexual Offenders Act 2006
New South Wales High Risk Offenders Act 2017

These laws require psychiatric assessment of whether the individual has a diagnosed mental disorder and poses an unacceptable risk of reoffending. Forensic psychiatrists must render an opinion on both the presence of a diagnosable mental disorder and public safety risk upon release. The RANZCP emphasises that forensic psychiatric opinion must remain clinically grounded and independent of punitive intent.

Fitness and Criminal Responsibility

Paraphilic disorder does not in itself negate criminal responsibility. Assessment of fitness to stand trial and mental state at the time of the offence follows standard forensic psychiatric principles under relevant state and territory Mental Health Acts.

Confidentiality and Mandatory Reporting

Clinicians treating individuals with paraphilic disorders, particularly pedophilic disorder, must balance therapeutic confidentiality with mandatory reporting obligations under child protection legislation. In Australia, all jurisdictions impose mandatory reporting obligations for suspected child abuse; duty-to-warn obligations may apply where an identifiable potential victim exists.

Castration: Surgical and Chemical

Informed Consent and Coerced Treatment

Linking medical treatment (antiandrogens) to release from custody conflates punishment with treatment and raises fundamental informed consent concerns. Ethical practice requires treatment that is evidence-based, respects human dignity, and aims at genuine rehabilitation rather than social control.

Therapist Ethics in Sex Offender Treatment


Key Exam Points

Domain High-Yield Fact
DSM-5-TR definition Paraphilia ≠ paraphilic disorder; disorder requires Criterion B (distress/impairment OR harm/risk to others)
Course specifiers "In full remission" requires ≥5 years in uncontrolled environment; specifiers excluded from pedophilic disorder and unspecified categories
ICD-11 Replaced "Disorders of Sexual Preference"; introduced CSBD as separate entity in impulse-control disorders
Hypersexual Disorder Proposed for DSM-5 but rejected; not in DSM-5-TR
Pharmacotherapy sequence SSRIs → oral antiandrogens → depot GnRH agonists
GnRH agonists Require DEXA monitoring, calcium/vitamin D; castrate testosterone levels
Psychological treatment CBT and strength-based models (GLM, RNR) are current standard; relapse prevention models largely superseded
Recidivism Incest offenders recidivate at ~half the rate of extrafamilial child molesters
Paraphilic crossover One paraphilic disorder increases risk of others; crossover across victim type, age, and relationship documented
Late-onset paraphilic behaviour Neurological aetiology must be excluded (FTD, TBI, Huntington, dopaminergic medications)
Objective testing Phallometry does not rely on self-report; also used to monitor treatment response
APA on castration laws "Objectionable… improperly link medical treatment with punishment and social control"

Sources

Primex

Practice this topic in the app

Sit a graded SAQ on this exact LO, run a voice viva with the AI examiner, or work through MCQs that map to RANZCP_S2_A15.11, RANZCP_S2_C5.3. Your free trial covers all 21 exams.

Start 7-day free trial

Quick recall flashcards

A small sample of the deck for this topic. Tap a question to reveal the answer. The full deck and spaced-repetition scheduler live inside Primex.

How does DSM-5-TR classify the main categories of sexual disorders?
  • Sexual dysfunctions (e.g., erectile disorder, female orgasmic disorder, genito-pelvic pain/penetration disorder)
  • Paraphilic disorders (e.g., voyeuristic, exhibitionistic, fetishistic, pedophilic disorder)
  • Gender dysphoria (separate chapter)
  • Note: sexual dysfunction due to substance/medication or another medical condition are specified subtypes
What are the DSM-5-TR male sexual dysfunctions?
  • Erectile disorder
  • Delayed ejaculation
  • Early (premature) ejaculation
  • Male hypoactive sexual desire disorder
  • Substance/medication-induced sexual dysfunction
  • Sexual dysfunction due to another medical condition
What are the DSM-5-TR female sexual dysfunctions?
  • Female sexual interest/arousal disorder
  • Female orgasmic disorder
  • Genito-pelvic pain/penetration disorder (replaced DSM-IV vaginismus and dyspareunia)
  • Substance/medication-induced sexual dysfunction
  • Sexual dysfunction due to another medical condition
What is the minimum duration criterion for most DSM-5-TR sexual dysfunctions?

Symptoms must be present for approximately 6 months or more and cause clinically significant distress in the individual.

Start free trial